Pfizer shares rose 0.5% in premarket trading on Tuesday after the company reported first-quarter earnings and revenue that topped expectations. Pfizer also kept its full-year outlook unchanged, giving investors some reassurance as the company faces a tough period of patent expirations through the end of the decade.
Pfizer reported adjusted earnings of 75 cents per share, beating the analyst estimate of 72 cents. Revenue for the quarter reached $14.5 billion, above the $13.8 billion expected by Wall Street. The chief financial officer pointed to 22% operational revenue growth, thanks to new and acquired products. This suggests Pfizer’s efforts to expand its portfolio are starting to pay off.
Pfizer kept its full-year forecast for adjusted earnings at $2.80 to $3.00 per share and revenue between $59.5 billion and $62.5 billion, which matches what analysts expected. Management also said the outlook does not factor in any share buybacks in 2026.
This steady outlook comes as Pfizer faces a major period of patent expirations, with protections on important drugs like Eliquis ending before the decade is over. To address this, Pfizer is both working with generic drug makers to extend patents for some products, such as Vyndaqel, and expanding its pipeline through acquisitions and in-house development to make up for expected revenue losses from new competition.
Featured Courses
Recent news
OpenAI Weighs 5% U.S. Government Stake Ahead of Blockbuster IPO
OpenAI has held discussions about offering the U.S. government a 5% ownership stake, potentially structured through a sovereign wealth fund, according to a Financial Times report citing people familiar with the matter. The ChatGPT maker did not immediately respond to a request for comment. The move would add Washington to an already formidable roster of […]
Tesla Deliveries Loom as Investors Bet on Second Straight Quarterly Gain
Tesla is poised to report second-quarter delivery figures Thursday morning, capping a period marked by geopolitical conflict, a spike in oil prices, and continued fallout from shifting U.S. electric-vehicle policy. The automaker’s shares have rallied sharply ahead of the report, a signal that investors anticipate a strong outcome. Even so, forecasts vary widely enough that […]
Nvidia Stock Trails Chip Peers in First Half as Competition Broadens
Nvidia shares rose 0.4% to $195.75 in premarket trading on Tuesday, ending a first half that trailed the broader semiconductor sector. The stock is up 4.5% for the year through Monday, much less than the PHLX Semiconductor Index’s 94% gain over the same period. Here’s a look at why Nvidia has underperformed and what investors […]
Trade with fewer limits
Day trade with fewer limits at fast speed. Buy stocks and ETFs at low fees.